Fagron NV
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
16 feb 2011 - 07:40
Statutaire naam
Fagron NV
Titel
REBITDA, EBIT and recurrent net profit increase double digit and faster than turnover
Bericht
Strong performance by Fagron, Arseus Medical & Corilus
Key points 2010:
Turnover growth of 8.4% to EUR 424.1 million
REBITDA increases 14.7% to EUR 60.4 million
EBIT increases 17.9% to EUR 36.0 million
Recurrent net profit per share increases 21.0% to EUR 0.98
Dividend proposal 2010: EUR 0.44 per share, 22% higher than in 2009
Outlook for 2011: Turnover growth of between 8% and 12%, organic turnover growth of between 3% and 6% and a REBITDA that is expected to grow faster than turnover
Datum laatste update: 24 februari 2026